SK Capital Partners Acquires Apotex Pharmaceutical Holdings

Apotex Acquires Searchlight Pharma

April 2, 2024

Pharmaceuticals

Apotex Inc. has completed the acquisition of Montreal-based Searchlight Pharma Inc., integrating Searchlight as Apotex's Specialty Pharma Division to expand its branded and specialty pharmaceutical capabilities. The deal adds Searchlight's portfolio of more than 60 products across women's health, dermatology, allergy, pain management and hospital specialty markets, and strengthens Apotex's commercial footprint in Quebec and across the Americas.

Skyline Global Partners Makes Minority Growth Investment in Apex International

June 1, 2024

Manufacturing

Skyline Global Partners LLC closed a minority growth equity investment in Apex International in June 2024; financial terms were not disclosed. The capital will be used to support Apex’s growth (including pursuit of add-on acquisitions) as the contract manufacturer expands capacity for personal care and OTC products from its Minnesota facilities.

SK Capital Partners Acquires Majority Stake in SEQENS

December 16, 2021

Pharmaceuticals

Funds advised by SK Capital Partners acquired a majority shareholding in SEQENS, investing alongside Bpifrance, Nov Santé, Mérieux Equity Partners, Ardian, Eximium and SEQENS' management. The deal includes the integration of Wavelength Pharmaceuticals into SEQENS and the prior divestiture of certain non-core mineral specialties assets; SEQENS emerges as a strengthened pharmaceutical CDMO with ~€1.1bn revenue and ~3,200 employees.

Turnspire Capital Partners Completes Acquisition of Pharmachem Innovations from Ashland

September 3, 2024

Food & Beverage

Turnspire Capital Partners has acquired Pharmachem Innovations, the former nutraceuticals business of Ashland Inc., creating an independent nutraceuticals platform. Pharmachem — a provider of proprietary nutrition ingredients, custom formulation and contract manufacturing with ~500 employees across facilities in New Jersey, Utah and Tamaulipas, Mexico — will be led by Executive Chairman Maurice Murphy and Interim CEO Jeff Rogers as Turnspire pursues operational growth opportunities.

SK Capital Partners Acquires IPACKCHEM Group SAS

April 6, 2021

Manufacturing

SK Capital Partners, a New York-based private investment firm focused on specialty materials and chemicals, has completed the acquisition of IPACKCHEM Group SAS, a Paris-headquartered manufacturer of sustainability-oriented barrier plastic packaging for the crop protection and specialty chemicals markets. SK Capital said it will partner with IPACKCHEM's management to accelerate organic and acquisitive growth and expand the company's global market position.

Odyssey Investment Partners Acquires ProPharma Group

September 22, 2020

Healthcare Services

Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.